-
Mashup Score: 5European Urology (@euro_urol) • Instagram photos and videos - 2 month(s) ago
7,940 Followers, 8 Following, 544 Posts – See Instagram photos and videos from European Urology (@euro_urol)
Source: www.instagram.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3Journal of the American Heart Association | About | AHA/ASA Journals - 4 month(s) ago
In March of 2024, JAHA published a Spotlight in conjunction with the 2023 Health Equity and Actionable Disparities in Stroke 2023 (HEADS UP) symposium. HEADS UP is a collaborative initiative with the American Stroke Association and National Institute of Neurological Disorders and Stroke. Established in 2020, it is the first annual multidisciplinary scientific forum focused on inequities in cerebrovascular disease, with the overarching goal of accelerating translation of research findings to practice, to
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet-
New JAHA #Spotlight: Health Equity and Actionable Disparities in Stroke 2023 The HEADS-UP initiative aims to reduce inequities in cerebrovascular disease. The 2023 symposium theme was implementation science. Read the articles at https://t.co/jJgE6GHOO1 https://t.co/Des45Trdw4
-
-
Mashup Score: 3European Urology (@euro_urol) • Instagram photos and videos - 5 month(s) ago
7,940 Followers, 8 Following, 544 Posts – See Instagram photos and videos from European Urology (@euro_urol)
Source: www.instagram.comCategories: General Medicine News, UrologyTweet-
Spotlight: The role of 99m Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-Analysis by @BasileG_e et al Watch all our Spotlights here: https://t.co/PNeAze6nnS #Spotlight… https://t.co/PXEPij1gqs https://t.co/mbhfpCWNTt
-
-
Mashup Score: 3European Urology (@euro_urol) • Instagram photos and videos - 5 month(s) ago
7,940 Followers, 8 Following, 544 Posts – See Instagram photos and videos from European Urology (@euro_urol)
Source: www.instagram.comCategories: General Medicine News, UrologyTweet-
Spotlight: The role of 99m Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-Analysis by @BasileG_e et al Watch all our Spotlights here: https://t.co/PNeAze6nnS #Spotlight… https://t.co/PXEPij1gqs https://t.co/mbhfpCWNTt
-
-
Mashup Score: 3Journal of the American Heart Association | About | AHA/ASA Journals - 9 month(s) ago
In March of 2024, JAHA published a Spotlight in conjunction with the 2023 Health Equity and Actionable Disparities in Stroke 2023 (HEADS UP) symposium. HEADS UP is a collaborative initiative with the American Stroke Association and National Institute of Neurological Disorders and Stroke. Established in 2020, it is the first annual multidisciplinary scientific forum focused on inequities in cerebrovascular disease, with the overarching goal of accelerating translation of research findings to practice, to
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet-
New JAHA #Spotlight: Health Equity and Actionable Disparities in Stroke 2023 The HEADS-UP initiative aims to reduce inequities in cerebrovascular disease. The 2023 symposium theme was implementation science. Read the articles at https://t.co/jJgE6GHOO1 https://t.co/Des45Trdw4
-
-
Mashup Score: 3Journal of the American Heart Association | About | AHA/ASA Journals - 9 month(s) ago
In March of 2024, JAHA published a Spotlight in conjunction with the 2023 Health Equity and Actionable Disparities in Stroke 2023 (HEADS UP) symposium. HEADS UP is a collaborative initiative with the American Stroke Association and National Institute of Neurological Disorders and Stroke. Established in 2020, it is the first annual multidisciplinary scientific forum focused on inequities in cerebrovascular disease, with the overarching goal of accelerating translation of research findings to practice, to
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet-
New JAHA #Spotlight: Health Equity and Actionable Disparities in Stroke 2023 The HEADS-UP initiative aims to reduce inequities in cerebrovascular disease. The 2023 symposium theme was implementation science. Read the articles at https://t.co/jJgE6GHOO1 https://t.co/Des45Trdw4
-
-
Mashup Score: 1Arineta announces SpotLight Duo - 1 year(s) ago
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT (CCT) scanners. The two products extend Arineta’s leadership as the only dedicated cardiovascular CT system, and the Duo system adds high resolution thoracic clinical capability, including for lung cancer, COVID19, and other pulmonary diseases. Both the SpotLight and SpotLight Duo systems add extended coverage for peripheral vascular and runoff studies, a rapidly growing procedure for vascular therapies. “Arineta has been the leader in cardiovascular CT technology, and the new SpotLight systems continue Arineta’s history of clinical innovation,” said Scott Schubert, Arineta CEO. “Our vision is to grow cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease- the number one cause of death and costs for healthcare worldwide.” “The recent change in guidelines from the ACC
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ArinetaCardio #Arineta #CardiacImaging announced the #FDA 510(k) clearance of the #SpotLight and #SpotLightDuo family of #cardiovascular #CT (#CCT) scanners: https://t.co/Qj3RE4Th7Z
-
-
Mashup Score: 5
ASTRO 2023 phase 3 SPOTLIGHT study, novel prognostication techniques for prostate cancer, 18F-rhPSMA-7.3, post-hoc analysis of SPOTLIGHT data, prostate cancer recurrence, PSMA-targeting ligand.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Detection rate of 18F-rhPSMA-7.3 PET in patients with suspected #ProstateCancer recurrence at PSA levels 1 ng/mL: data from the phase 3 #SPOTLIGHT study. Presented by Ashesh Jani, MD @EmoryUniversity. #ASTRO23 written coverage by @zklaassen_md > https://t.co/cpSu0JTbt4 @ASTRO_org https://t.co/VPugELThBu
-
-
Mashup Score: 0
SNMMI 2023, LIGHTHOUSE Trial, SPOTLIGHT trial, 18F-rhPSMA-7.3 PET/CT, ureteric activity, PSMA-targeting PET radiopharmaceutical.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Post-hoc analysis of the #LIGHTHOUSE and #SPOTLIGHT studies to assess the impact of urinary activity on interpretation of 18F-rhPSMA-7.3 PET/CT. Presented by Phillip Kuo @uarizona. #SNMMI23 coverage by @zklaassen_md @GACancerCenter > https://t.co/qpTK0IX34Y @SNM_MI https://t.co/rlde325WxN
-
-
Mashup Score: 0
Results of the SPOTLIGHT trial were presented at the AUA 2023 Annual Meeting. 18F-rhPSMA-7.3 has a high affinity and potential for low bladder activity.
Source: GU Oncology NowCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The phase 3, multicenter, single-arm #SPOTLIGHT study investigated the safety and efficacy of 18F-rhPSMA-7.3, a novel PSMA PET radiopharmaceutical, in patients with #prostatecancer with recurrence after primary treatment with radiation therapy. Learn more: https://t.co/Nvy96fyoMW https://t.co/r4dSWXGxvf
-
Spotlight: The role of 99m Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-Analysis by @BasileG_e et al Watch all our Spotlights here: https://t.co/PNeAze6nnS #Spotlight… https://t.co/PXEPij1gqs https://t.co/mbhfpCWNTt